Actogenix

Engineering microbes for in situ expression and secretion of novel biotherapeutic proteins and peptides.

placeGhent, Flanders, Belgium calendar_todayFounded 2006 groups5 employees language actogenix.com

Innovation

24 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,762 times.

YearFilings
20125
20138
20147
20153
20165
20174
20182
20192
20201
20212

Investor mix

10 investors on record; 4 have since exited.

Investor typeCountShare
Venture capital330%
Private equity440%
Other / undisclosed330%
Coming soon